Clinical Trials Logo

Fetal Distress clinical trials

View clinical trials related to Fetal Distress.

Filter by:

NCT ID: NCT05147584 Terminated - Fetal Distress Clinical Trials

Trans-abdominal Fetal Pulse Oximetry

Start date: July 20, 2022
Phase: N/A
Study type: Interventional

The Raydiant Oximetry Sensing System (Lumerah) is a non-invasive fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive, transabdominal near-infrared spectroscopy. Lumerah is intended as an adjunct to cardiotocography by detecting decreases in fetal oxygenation.

NCT ID: NCT04986475 Completed - Anxiety Clinical Trials

Music Therapy on High Risk Pregnant Women of Non-Stress Test

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Non-stress testing (NST) is one of the most commonly used methods to assess fetal health in the prenatal period because it is an easily interpreted, non-invasive, painless, and short-term diagnostic method. Although NST is a non-invasive and painless diagnostic method, pregnant women may feel anxiety during the procedure. It is supported by studies that listening to music causes relaxation and reducing anxiety. Therefore, the use of music as a non-pharmacological practice will increase the quality of care of individuals. There are many studies suggesting that music reduces anxiety in low-risk pregnancies during NST application. Different instruments such as ney, rebab, kopuz, dombra are used in Turkish music. In particular, ney has come to the fore in music therapy. The ney, which has different types in history, is an instrument that is closest to the human voice. In a compilation about the music used in music therapy in Turkey, it was stated that there are many social and health studies made with the sound of ney. Determining the effect of music on NST and anxiety in high-risk pregnant women will contribute to the literature.

NCT ID: NCT04548453 Not yet recruiting - Pregnancy Related Clinical Trials

Establish the uSI Values and End-user Training Material That Will be Used to Guide Oxytocin Dosing Actions

uSI-ranges
Start date: April 2021
Phase: Early Phase 1
Study type: Interventional

Patients receiving oxytocin for induction or augmentation of labor will be studied with uterine EMG. The results of the EMG will be converted to an oxytocin-associated uterine stimulation index (uSI), which is intended to guide decisions for changing the dose of oxytocin. An expert panel will review the results of the oxytocin dosing actions, then assigned optimized actions throughout the labor. The uSI will be correlated with the optimal dosing actions.

NCT ID: NCT04325243 Completed - Fetal Distress Clinical Trials

Sildenafil Citrate and Intrapartum Fetal Distress

Start date: September 1, 2020
Phase: Phase 4
Study type: Interventional

Induction of labour (IOL) is done for 20% of pregnancies for various maternal and fetal indications and nearly 20% of labour inductions end up in caesarean section. The most common causes are failed induction and intrapartum fetal distress. In spite of significant advances in methods of IOL and intrapartum fetal monitoring, no interventions are proven to reduce the development of intrapartum fetal distress

NCT ID: NCT04081623 Terminated - Fetal Distress Clinical Trials

Trans-abdominal Fetal Pulse Oximetry: Signal Integrity

Start date: April 16, 2019
Phase:
Study type: Observational

This project is set up to advance and integrate the established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters,

NCT ID: NCT04081584 Terminated - Fetal Distress Clinical Trials

Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering

Start date: July 1, 2019
Phase:
Study type: Observational

This study is being conducted to study light scattering properties of maternal-fetal tissue.

NCT ID: NCT04043299 Recruiting - Birth Asphyxia Clinical Trials

Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes

Intra-O
Start date: March 16, 2020
Phase: Phase 3
Study type: Interventional

Introduction Birth asphyxia is one of leading causes of neonatal mortality in Uganda. It is associated with long term neuro-developmental complications among the babies that survive. Preventive measures for birth asphyxia intrauterine are not clearly understood and thus the need for this study. The aim of the study is to assess the effect of intrapartum oxygen administration on fetal and early neonatal outcomes. Methods A double-blind randomized clinical trial which will be conducted in Gulu regional referral and Kawempe National referral hospitals in Uganda. A total sample size of 1108 women in labour will be enrolled with 554 participants per group. The intervention will include administration of 10 L/min of 100% oxygen for 15 minutes to women in established labor who have signs of fetal distress with fetal heart rate of less than 120 or above 160 beats per minute. The control group will receive medical air (21% oxygen) using the same criteria. Women and babies will be followed up until 7 days after birth to document the outcomes. Statistical analysis to identify difference in outcomes between the control and intervention groups will be performed. Ethical considerations Ethical approval and permission was received from relevant research and ethics committees. Informed consent will be sought from the participants. A data and safety monitoring board will be set up to review periodically the progress of the clinical trial study. Participants will be monitored for adverse events and severe adverse events; reporting will be done according to the research and ethics committee guidelines.

NCT ID: NCT03859037 Not yet recruiting - Fetal Distress Clinical Trials

Effect of Umbilical Cord Milking on Transition of Preterm Babies During Resuscitation

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Investigators will evaluate if milking of umbilical cord in preterm babies will improve transition during resuscitation or not

NCT ID: NCT03764696 Completed - Fetal Distress Clinical Trials

Maternal Oxygen Administration for Fetal Distress II

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Supplementary oxygen is routinely administered to patients, even those with adequate oxygen saturations, in the belief that it increases oxygen delivery. However, oxygen delivery depends not just on arterial oxygen content but also on perfusion. Maternal oxygen administration has been used in an attempt to lessen fetal distress by increasing the available oxygen from the mother. However, the effect of supplemental maternal oxygen therapy on fetal acid base status has been debated for more than seven decades. The investigators found the use of 2 L/min maternal oxygen during the second stage of labor did not adversely affect either the umbilical artery pH value or the fetal heart rate (FHR) pattern distribution.

NCT ID: NCT03536910 Completed - Fetal Distress Clinical Trials

Evaluation of Copeptin Levels in Elective Cesarean Section With Different Anesthetic Technique

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

In this study, investigators aimed to investigate the effects of general and spinal anesthesia techniques on copeptin levels during cesarean section and their relation with fetal distress.